Results
26,453 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner |  TEAMAtlassian CorpOpen-market sale · 10b5-1 plan | SELL | $265K 1,913 sh |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $265K 1,913 sh |
| Jan 27, 2026 traded Jan 26, 2026 |
| 9 |  Farquhar ScottDirector, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $265K 1,914 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 9 | Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $364K 2,663 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 9 | Farquhar ScottDirector, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $270K 1,987 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 9 | Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $270K 1,988 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 6 | Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $131K 951 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 6 | Farquhar ScottDirector, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $131K 950 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 3 | Farquhar ScottDirector, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $6,652 50 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 3 | Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $13K 100 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 3 | Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $6,652 50 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 3 | Farquhar ScottDirector, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $13K 100 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 62 | Rooney Robert GeraldDirector | NONETCW Private Asset Income Fund Open-market purchase | BUY | $281K 28.1K sh | Jan 26, 2026 traded Nov 10, 2025 |
| 59 | Rooney Robert GeraldDirector | NONETCW Private Asset Income Fund Open-market purchase | BUY | $113K 11.3K sh | Jan 26, 2026 traded Nov 10, 2025 |
| 41 | Cheng LawrenceDirector |  GMEGameStop Corp.Open-market purchase | BUY | $114K 5,000 sh | Jan 26, 2026 traded Jan 23, 2026 |
| 35 | Bhatia Manish HEVP, Global Operations |  MUMICRON TECHNOLOGY INCOpen-market sale | SELL | $1.99M 5,128 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 35 | Bhatia Manish HEVP, Global Operations | MUMICRON TECHNOLOGY INC Open-market sale | SELL | $3.32M 8,500 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 35 | Bhatia Manish HEVP, Global Operations | MUMICRON TECHNOLOGY INC Open-market sale | SELL | $2.81M 7,200 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 35 | Schwab-Pomerantz CarolynDirector |  SCHWSCHWAB CHARLES CORPOpen-market sale | SELL | $1.00M 9,525 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 35 | Schwab-Pomerantz CarolynDirector | SCHWSCHWAB CHARLES CORP Open-market sale | SELL | $2.00M 19.1K sh | Jan 26, 2026 traded Jan 22, 2026 |
| 35 | Schwab-Pomerantz CarolynDirector | SCHWSCHWAB CHARLES CORP Open-market sale | SELL | $1.00M 9,525 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 33 | Tpg Gp A, Llc10% Owner |  SIONSionna Therapeutics, Inc.Open-market sale | SELL | $10.00M 250.0K sh | Jan 26, 2026 traded Jan 22, 2026 |
| 33 | Sibold William JohnDirector, President and CEO |  MDGLMADRIGAL PHARMACEUTICALS, INC.Open-market sale | SELL | $777K 1,577 sh | Jan 26, 2026 traded Jan 26, 2026 |
| 32 | Bhatia Manish HEVP, Global Operations | MUMICRON TECHNOLOGY INC Open-market sale | SELL | $911K 2,300 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 32 | Schwab-Pomerantz CarolynDirector | SCHWSCHWAB CHARLES CORP Open-market sale | SELL | $500K 4,765 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 32 | Bhatia Manish HEVP, Global Operations | MUMICRON TECHNOLOGY INC Open-market sale | SELL | $511K 1,295 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 32 | Wilson Kelli AnnEVP Chief Banking Officer |  HFWAHERITAGE FINANCIAL CORP /WA/Open-market sale | SELL | $50K 1,900 sh | Jan 26, 2026 traded Jan 26, 2026 |
| 32 | Bhatia Manish HEVP, Global Operations | MUMICRON TECHNOLOGY INC Open-market sale | SELL | $864K 2,200 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 30 | Taub RebeccaDirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale | SELL | $319K 647 sh | Jan 26, 2026 traded Jan 26, 2026 |
| 29 | Beckwith Van H.EVP, Secretary and CLO |  HALHALLIBURTON COOpen-market sale · 10b5-1 plan | SELL | $1.90M 54.3K sh | Jan 26, 2026 traded Jan 23, 2026 |
| 27 | O'Day Daniel PatrickDirector, Chairman & CEO |  GILDGILEAD SCIENCES, INC.Open-market sale · 10b5-1 plan | SELL | $15.61M 115.6K sh | Jan 26, 2026 traded Jan 23, 2026 |
| 25 | Huntsman CaroleChief Commercial Officer | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $282K 570 sh | Jan 26, 2026 traded Jan 26, 2026 |
| 23 | Unruch JoelGeneral Counsel/Corp Secretary |  ACNAccenture plcOpen-market sale · 10b5-1 plan | SELL | $172K 610 sh | Jan 26, 2026 traded Jan 23, 2026 |
| 23 | Unruch JoelGeneral Counsel/Corp Secretary | ACNAccenture plc Open-market sale · 10b5-1 plan | SELL | $60K 214 sh | Jan 26, 2026 traded Jan 23, 2026 |
| 22 | Bachrodt AmySVP, Finance |  MAZEMaze Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $228K 5,000 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 21 | Mat IshbiaDirector, President and CEO, 10% Owner |  UWMCUWM Holdings CorpOpen-market sale · 10b5-1 plan | SELL | $3.64M 632.9K sh | Jan 26, 2026 traded Jan 26, 2026 |
| 21 | Urist MarshallEVP, Research & Investments |  RPRXRoyalty Pharma plcOpen-market sale · 10b5-1 plan | SELL | $805K 20.0K sh | Jan 26, 2026 traded Jan 23, 2026 |
| 20 | Unruch JoelGeneral Counsel/Corp Secretary | ACNAccenture plc Open-market sale · 10b5-1 plan | SELL | $39K 138 sh | Jan 26, 2026 traded Jan 23, 2026 |
| 20 | Unruch JoelGeneral Counsel/Corp Secretary | ACNAccenture plc Open-market sale · 10b5-1 plan | SELL | $18K 64 sh | Jan 26, 2026 traded Jan 23, 2026 |
| 19 | Slowe Christopher BrianChief Technology Officer |  RDDTReddit, Inc.Open-market sale · 10b5-1 plan | SELL | $278K 1,300 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 19 | Slowe Christopher BrianChief Technology Officer | RDDTReddit, Inc. Open-market sale · 10b5-1 plan | SELL | $447K 2,083 sh | Jan 26, 2026 traded Jan 22, 2026 |